Last update March 27, 2015
Low Risk
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Main tradenames from several countries containing Clebopride in its composition:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Benzamide derivative agent which is similar to Metoclopramide but with higher extrapyramidal side-effects and poorly known pharmacokinetics.
At latest update, relevant published data on excretion into breast milk were not found.
As with Metoclopramide it produces increased secretion of Prolactin.
Until more data on this medication is available, safer alternative drugs are preferred, especially in such critical age periods.